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Abstract  
 
Carpolobia lutea (G. Don) (Polygalaceae) is a tropical medicinal plant putative in traditional medicines 
against gonorrhea, gingivitis, infertility, antiulcer and malaria. The present study evaluated the antimicrobial, antifungal 
and antihelicobacter effects of extracts C. lutea leaf, stem and root. The extracts were examined using the disc-diffusion  
and Microplates of 96 wells containing Muller-Hinton methods against some bacterial strains: Eschericia coli (ATCC 
25922), E. coli (ATCC10418), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 25923), 
Staphyllococus aureus (ATCC 6571), Enterococcus faecalis (ATCC 29212) and Bacillus subtilis (NCTC 8853) and 
four clinical isolates:  one fungi (Candida albican) and three bacteria (Salmonella, Sheigella and staphylococcus 
aureus). The Gram-positive bacteria: Staphylococcus aureus (ATCC 25923), Enterococcus faecalis (ATCC 29212), 
Bacillus subtilis (ATCC 19659) and the Gram-negative bacteria: Escherichia coli (ATCC 25922), Pseudomonas 
aeruginosa (ATCC 27853), Cândida albicans (ATCC 18804) and Helicobacter pylori (ATCC 43504). Some of these 
extracts were found to be active against some tested strains but activity against H. pylori was >1000mg/ml and good 
fungistatic activity against C. albican. The MIC against C. albican is in the order n-HF > CHF > ETF= EAF.The order 
of potency of fraction was the ethanol root > n-HF leaf > ethanol fraction stem > chloroform fraction leaf = ethyl 
acetate fraction leaf. Polyphenols were demonstrated in ethanol fraction, ethyl acetate fraction, crude ethyl acetate 
extract and ethanol extract, respectively. These polyphenols isolated may partly explain and support the use of C. lutea 
for the treatment of infectious diseases in traditional Ibibio medicine of Nigeria. 
 
Keywords: Carpolobia lutea, Polygalaceae, antimicrobial, antifungal, antihelicobacter,  
                    Polyphenols  
 
 
 
Introduction 
 
      The shrub Carpolobia lutea G. Don (Polygalaceae) is a small tree which grows up to 15ft high (Hutchinson 
and Dalziel, 1954). It is widely distributed in West and Central areas of tropical Africa (Mitaine - Offer et al., 2002). It 
occurs  as a dense overgrowth or an evergreen shrub or small tree, up to 5m high. The leaf is 2-7.5cm long, 1-2.8cm 
broad; branches and mid-rib densely pubescence; lamina variable in shape, ovate, ovate-elliptic, oblong, or narrowly 
elliptic, obtuse or rounded at the base, more or less parallel and rather close. The flower is zygomorphic, often brightly 
colored.  The keel petal is about 16mm long, 3-4mm broad and broader than that of other petals; outer 3 sepals are 2-
5mm long, 3-5mm broad and smaller than the two inner sepals which is 6-7.5mm long and 3-6mm broad. Racemes 
contain 1-2 flowers. The fruit is fleshly yellow or red; seed very densely villous with copious fleshy endosperm 
(Hutchison and Dazel, 1968). The common names which the plant is known include cattle stick (English), Abekpok 
Ibuhu (Eket), Ikpafum, Ndiyan, Nyayanga (Ibibio), Agba or Angalagala (Igbo) and Egbo oshunshun (Yoruba).  
                The stem is used as chewing stick (Kayode and Omotoyinbo, 2008); the root is also used as chewing stick 
because of its aphrodisiac potentials. Its shrubby and smallish stems give it a ornamental use as sweeping material or 
broom (indiyan) in rural areas among the Ibibio tribes of Akwa Ibom State, Nigeria (Etukudo, 2003). The resilience of 
the woody stem enhances its patronage by cattle herders as cane to control their cattle heads.   
               The decoction of the root is used in locally-made alcohol as an aphrodisiac. It is used in the treatment of 
genitourinary infections, gingivitis and waist pains (Ettebong and Nwafor, 2009). The root decoction is also useful in 
the treatment of internal heat. The hot water extract of the root was reported to have antimicrobial activity (Malcolm 
and Sofowora, 1969). The plant (C. lutea) has been reported to possess anti-inflammatory and anti-arthritic properties 
(Iwu and Anyanwu, 1982), gastro-protective effects (Nwidu and Nwafor, 2009); antinociceptive effects (Nwidu et al., 
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2011); antimicrobial activities (Ajibesin, 2005; Philip et al., 2005); antidiarrhoeal and anti-ulcerogenic properties 
(Nwafor and Bassey, 2007); antimalarial activity and moderate toxicity (Bero et al., 2009). The antimicrobial effects of 
the root have been established (Ettebong and Nwafor, 2009). The root is used to facilitate childbirth, treat sterility, 
headache, worm infestation and as aphrodisiac and stimulant properties (Mitaine-Offer et al., 2002). It has analgesic, 
androgenic properties and it is reputed to cure rheumatism, fever and to combat sterility. The leaf is reported to be used 
in the management of fever accompanying diarrhea, headache, leprosy, snakebite, venereal disease, wounds (Ajibesin 
et al 2007; Lewis and Elvin-Lewis, 1977).  
            Three new triterpene saponins were isolated from the root (Mitaine-Offer et al., 2002). Polyphenols have been 
isolated from the leaf of C. lutea   (Nwidu et al., 2011). It has been suggested that polyphenols are responsible for the 
antibacterial effects upon Streptococcus mutans (Kakiuchi et al., 1986). This could be related to polyphenols action as 
mediators in cell membrane and oxidative phosphorylation at low concentrations (Scalbert et al., 2005). However, only 
recently, polyphenols in fruits and leaves have received attention regarding their antibacterial effect upon 
microorganisms in biofilms (Huber et al., 2003; Duarte et al., 2006; Percival et al., 2006). Hence, the aim of this study 
is to screen the gradient fractions (n-hexane, chloroform, ethyl acetate and ethanol) and crude ethyl acetate extract of 
the leaf, crude ethanol extract of the stem and crude ethanol extract of the stem for antimicrobial activity. Besides, 
submit the most active fraction to preparative TLC to isolate and characterized active compounds. The goal is to verify 
ethnonomedical antimicrobial claim of the effectiveness of the extract of leaf, stem and root of C. lutea used by Efik 
people in Nigeria in the treatment of toothache, menstrual pain, urinary tract infection and stomach ache.  This 
investigation will also confirm earlier antimicrobial report on the root (Ettebong and Nwafor, 2009). 
 
 
 
Materials and Methods 
Plant Material  
                
  C. lutea leaves, stem and root were collected and supplied by Mr. Etefia, the traditional herbalist, attached to 
the Pharmacognosy Department, University of Uyo. The plant was identified and authenticated by Dr. (Mrs.) Margaret 
Bassey of Department of Botany, University of Uyo, Akwa Ibom State, Nigeria. A voucher specimen (UUH 998) was 
deposited at the University Herbarium. The leaf, stem and root were air-dried, powdered with pestle and mortar. The 
pulverized materials were stored at room temperature.  
 
Test organisms 
 
             Six organisms used in this study as test organisms were seven typed cultures of bacteria: Eschericia coli 
(ATCC 25922), E. coli (ATCC10418), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 
25923), Staphyllococus aureus (ATCC 6571), Enterococcus faecalis (ATCC 29212) and Bacillus subtilis (NCTC 
8853) and four clinical isolates:  one fungi (Candida albican) and three bacteria (Salmonella, Sheigella and 
staphylococcus aureus). The Gram-positive bacteria: Staphylococcus aureus (ATCC 25923), Enterococcus faecalis 
(ATCC 29212), Bacillus subtilis (ATCC 19659) and the Gram-negative bacteria: Escherichia coli (ATCC 25922), 
Pseudomonas aeruginosa (ATCC 27853), Cândida albicans (ATCC 18804) and Helicobacter pylori (ATCC 43504) 
were obtained from the Microbiology Department, Faculty of Pharmaceutical science, Sao Paulo University. The 
remaining typed organisms and clinical isolates were obtained from the Pharmaceutical Microbiology Unit of the 
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, University of Uyo, Uyo. The 
typed cultures of bacteria and clinical isolates of fungi were sub-cultured on nutrient agar (Oxoid) and saboraud 
dextrose agar (Oxoid) slants respectively and stored at 4oC until used.           
 
Antimicrobial agents 
 
The following chemotherapeutic agents were included in the test as positive controls: ciprofloxacin1mg/ml, 
nystatin 25,000 I.U/ml and fluconazole 65 μg/mL. 
 
Preparation of extract 
 
               The plant leaf, stem and root were air-dried at 45˚C and pulverized using harmer mill into fine powder. The 
leaf was sequentially extracted by cold maceration for 72 hr using 2.5L of n-hexane (n-HF), chloroform (CHF), ethyl 
acetate (EAF) and ethanol (ETF) as solvents. These were then filtered and the filtrates were concentrated under reduced 
pressure by the use of rotary evaporator (BUCHI, USA) at 40˚C. The crude extracts: ethyl acetate extract of leaf 
(EAEL) and ethanol extract (ETEL) of the leaf, the ethanol extract (ETES) of the stem and  ethanol extract of the root 
(ETER)  were obtained after 72 hrs of maceration in respective solvent; each solvent was filtered and concentrated 
under reduced pressure as above. The dry weight of the fractions and extracts were obtained by allowing the 
evaporation of the solvent to take place in fume cupboard. These percentage yielded dry fractions of n-HF (3.66%), 
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CHF (3.03%), EAF (3.63%), ETF (15.07%), EAEL (7.82%), ETEL (27.08%), ETES (21.72%), and ETER (54.09%) 
respectively. These fractions and extracts were subsequently kept in sterile bottles at -4˚C pending use.  n-HF, CHF, 
EAF, ETF, EAEL, ETEL, ETES and ETER were used to determine the concentration in mg/ml. 
 
Extraction and Fractionation of C. lutea 
 
                    Procedure of gradient solvent extraction is as described in earlier report (Nwidu and Nwafor, 2009). The 
chemical constituents present in C. lutea were analyzed according to Wagner et al. (1984) and this has been reported in 
Nwidu et al., 2011.  
 
Evaluation of antibacterial activity  
 
                The evaluation of antibacterial and the determination of MIC were done by the micro-dilution technique 
based on the M7-A6 of the national committee for Clinical and standards with modification (NCCLS, 2003).  Bacterial 
cultures were cultivated in caldo Muller-Hinton (Difco) and transferred to phosphate solution of PH 7.2 and turbidity 
adjusted  up to scale 0.5 of  McFarland (108 cells/mL), and in the second dilution was adjusted 1:10 concentration for   
107 cells/ mL  which was therefore used in the tests. Microplates of 96 wells were utilized and each well filled with 
sterilized Muller-Hinton.  The inoculums and the diluted extract of the solution were made up to 100 μL. The solution 
of the extract was prepared in concentration of 2000μg/ml and was diluted serially up to 3.75 μg /mL. For the positive 
control, a solution of ciprofloxacin 35 μg/mL was used. For the negative control, the environment, the solvent and the 
inoculums were sterilized. The results were evaluated based on turbidity observed in the test wells using colorimetric 
evaluation resazurina as the indicator.  The wells with blue colored showed activity whereas the wells with no activity 
were pink in color. The Gram-positive bacteria used were Staphylococcus aureus (ATCC 25923), Enterococcus 
faecalis (ATCC 29212), Bacillus subtilis (ATCC 19659) and the Gram-negative bacteria used were Escherichia coli 
(ATCC 25922) and Pseudomonas aeruginosa (ATCC 27853). 
 
Evaluation of antifungal activity 
 
                 The evaluation of the antifungal activity and the determination of the MIC were done by the technigue of 
microdilution according to the methodology described by M27-A2 da Nacional Committee for Clinical Laboratory 
Standards (NCCLS, 2002) with some modifications. Cândida albicans (ATCC 18804)  cultures in sabouraud dextrose 
agar (Difco) were incubated for 48 hrs and transferred to 0.85% saline  solution and turbidity adjusted to 0.5 de 
McFarland (108 céls/mL) and the concentration made up to 2.5 x 103 cells/mL  which was therefore used for the test. 
Microplates with 96 wells were used and each well filled with RPMI 1640 liquid, adjusted to a pH of 7.0 by MOPS 
before sterilization through membrane filtration. The volume of the extract was first solibulised and the volume made 
up to 100µL in each well.  The solutions of the extract were prepared in concentration of 2000 μg/mL to 3.75 μg/mL by 
serial dilution.  The positive control drug used is fluconazole at a concentration of 65 μg/mL. For the negative control, 
the environment, the inoculums and the extract were sterilized. The evaluation of the results were done by observing 
the turbidity occurring in each well and also colorimetric evaluation was done using  Triphenyl tetrazolium chloride 
(TTC) as an indicator.  The wells with no color change had activity while the wells with fungal growth show red color. 
 
The Evaluation of Anti-Helicobacter pylori 
 
              The Helicobacter pylori (ATCC 43504) cultures were incubated at -80 ˚C in Mueller-Hinton agar containing 
5% bovine serum and 20% glycerol. The stock was replicated in Mueller –Hinton agar containing 10% sheep blood and 
incubated 37 ˚C for 72 hrs in anaerobic atmosphere with 10% CO2 and 98% humidity. The H. pylori cells were 
suspended in a sterile saline solution until a turbidity of 0.5 de McFarland was obtained. Muller-Hinton agar was 
utilized to test the susceptibility. A  Whatman paper disc of 6mm were prepared, sterilized and impregnated with each 
25µL of extract or solvent. The bacterial inoculum was placed in the wells using sterile swab. The wells were dried for 
3-5 mins. After drying the entire discs were placed in the wells maintaining a distance of 15mm to avoid overlaps in the 
zones of inhibition. Discs containing 35µg of ciprofloxacin and DMSO or methanol 25% were impregnated and 
utilized as controls. 15 mins after inoculation of  the disc, the wells of H. pylori were incubated at 37 ˚C for 2-5 days in 
micro aerobic atmosphere of 98% humidity after this period, the diameter of zone of inhibition was measured (NCCLS, 
2003; Hirumi-Lima et al., 2008).  
 
 
Results and Discussion 
 
The results of the antimicrobial activities when tested at the pharmacological doses are as shown in Tables 1 
and 2.  
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Table 1: Antimicrobial activity of C. lutea leaf extract and fractions 
 
                 
               Medicinal plants constitute an effective source of both traditional and modern medicines. Herbal medicine has 
been shown to have genuine utility and about 80% of rural population depends on it for primary health care. The 
evaluation of antibacterial potentials of various plants is imperative as infections are known to be caused by 
microorganisms’ especially genitourinary infections. The MIC of the various fractions and extract tested the order of 
susceptibility of the tested organism is B. subtilis > C. albican > E. faecalis  >  E. coli > S.aureus = P. aurogenosa = 
H.pylori.  For B.subtilis the order of activity of MIC of the plant parts is root > stem > leaf. The commonest cause of 
infertility in women in Nigeria is infection, particularly pelvic inflammatory disease (Abudu, 1985; Otubu, 1985).  B. 
subtilis, is known to be responsible endocarditis, fatal pneumonia, bacteremia, septicemia and infection of a necrotic 
axillary tumor. B. subtilis have been isolated from surgical wound-drainage sites, from a subphrenic abscess from 
abreast prosthesis, and from two ventriculo-atrial shunt infections (Logan, 1988).  
The plant extract and fractions were very effective against gram positive organism than gram negative 
organism and this has been corroborated for the root fractions by Ettebong and Nwafor, (2009).  The MIC of the plants 
fractions and extract for gram negative organisms were greater than 1000µg/ml. The gastroprotective effectiveness of  
 
 
 
 
Organisms 
Conc/ml 
 
Mg/ml 
Ethyl 
acetate 
crude 
Ethanol 
fraction 
Ethyl 
acetate 
fraction 
Chloroform 
fraction 
n-Hexane 
fraction 
Cipro 
1mg/ml 
E.coli 10418 192.5 
385.0 
770.0 
14.0 
16.2 
18.0 
 
 
15.0 
15.0 
18.0 
22.0 
 
 
- 
 
 
- 
 
 
30.2 
Salmonella  192.5 
385.0 
770.0 
14.0 
16.2 
21.0  
 
 
14.5 
16.0 
18.0 
22.0 
 
 
14.0 
 
 
11.0 
 
 
31.0 
Staphyllococus 
aureus 25923 
192.5 
385.0 
770.0 
15.0 
18.0 
22.0 
 
 
25.0 
20.0 
28.0 
32.0 
 
 
14.0 
 
 
- 
 
 
 
35.0 
Pseudomonas 192.5 
385.0 
770.0 
- 
- 
- 
 
 
13.0 
- 
16.0 
20.0 
 
 
- 
 
 
- 
 
 
24.0 
B.subtilis 192.5 
385.0 
770.0 
14.0 
18.0 
20.0 
 
 
18.0 
18.0 
21.0 
30.0 
 
 
16.0 
 
 
10.0 
 
 
41.0 
E.coli 25922 192.5 
385.0 
770.0 
10.0 
16.0 
18.0 
 
 
18.0 
16.0 
18.0 
21.0 
 
 
- 
 
 
- 
 
 
30.0 
Candida albican 192.5 
385.0 
770.0 
12.0 
16.2 
18.0 
 
 
14.0 
16 
21 
24 
 
 
- 
 
 
- 
 
 
22 
 
Staphyllococus 
aureus 
Clinical isolates 
192.5 
385.0 
770.0 
14.0 
16.0 
19.5 
 
 
18.0 
20.0 
26.0 
32.0 
 
 
15.0 
 
 
- 
 
 
31 
Sheigella 192.5 
385.0 
770.0 
10.5 
14.0 
16.0 
 
 
20.0 
15 
18.0 
22.0 
 
 
18.0 
 
 
15.0 
 
 
35.0 
Staphyllococus 
aureus 6571 
192.5 
385.0 
770.0 
12.0 
16.5 
18.0 
 
 
26.0 
16.0 
17.5 
20.0 
 
 
18.0 
 
 
14.2 
 
 
32.0 
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Table 2: Minimum inhibitory concentration (µg/mL) of of different extract and fractions of 
              C. lutea 
 
Extracts/ 
Fractions S. aureus B. subtilis E. coli E. faecalis 
P. 
aeruginosa C. albicans H. pylori 
EAF Lf - 1000 - 1000 - - - 
ETF Lf - - - - - - - 
ETE  Stem - 250 - 1000 - 1000 - 
ETE Lf - - 1000 - - - - 
EAE Lf - 500 - - - 1000 - 
ETE rt - 31.25 - - - - - 
n-HF Lf - - - - - 125 - 
CHF Lf - - - - - 500 - 
Positive control: ciprofloxacin (35 µg/mL) 
(-): CIM > 1000 µg/mL 
Solvent utilized: n-HF = DMSO 20 %; CHF = DMSO 20 %; Demais extratos = Methanol 25% 
 
the leaf extract (Nwidu and Nwafor, 2009) may not be related to anti-helicobacter activity. However the plants parts 
demonstrate good fungistatic activity against C. albican. The MIC against C. albican is in the order n-HF > CHF > 
ETF= EAF.   The order of potency of fraction was the ethanol root > n-HF leaf > ethanol fraction stem > chloroform 
fraction leaf = ethyl acetate fraction leaf. The chloroform fraction of the root has been reported the most potent against 
Gram negative organism (Ettebong and Nwafor, 2009). The high doses of the plant leaf fractions and extract used in 
the pharmacological studies demonstrate proven antimicrobial activity. The ethyl acetate fraction and the crude ethyl 
acetate extract where more effective than the other fractions. The polyphenolics compounds have been implicated as 
potent antibacterial agents in some studies (Huber et al., 2003; Duarte et al., 2006; Percival et al., 2006). The 
quantification of total phenolics for the polar extract and fractions revealed that the percentage of total phenolics 
content increased from 61.33, 78.67, and 90.78 to 136.22 µg/ml for ethanol fraction, ethyl acetate fraction, crude ethyl 
acetate extract and ethanol extract, respectively (Nwidu, 2010). The high concentration of polyphenols in the leaf 
fraction isolated might lend credence to observed activity. The results of this study lend acceptance to the ethnomedical 
use of the root, stem, and leaf in the treatment of sterility, genitourinary infection and gingivitis among Effik people of 
Nigeria. 
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